388 related articles for article (PubMed ID: 15328336)
1. Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion.
Korn T; Magnus T; Toyka K; Jung S
J Leukoc Biol; 2004 Nov; 76(5):950-60. PubMed ID: 15328336
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats.
Rott O; Cash E; Fleischer B
Eur J Immunol; 1993 Aug; 23(8):1745-51. PubMed ID: 8393796
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis.
Weinberg AD; Whitham R; Swain SL; Morrison WJ; Wyrick G; Hoy C; Vandenbark AA; Offner H
J Immunol; 1992 Apr; 148(7):2109-17. PubMed ID: 1347550
[TBL] [Abstract][Full Text] [Related]
5. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
[TBL] [Abstract][Full Text] [Related]
6. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
[TBL] [Abstract][Full Text] [Related]
8. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
9. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Donhauser T; Toyka KV; Hartung HP
J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
[TBL] [Abstract][Full Text] [Related]
10. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
Ramírez F; Mason D
Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
[TBL] [Abstract][Full Text] [Related]
11. Interaction with antigen-specific T cells regulates expression of the lactate transporter MCT1 in primary rat astrocytes: specific link between immunity and homeostasis.
Korn T; Magnus T; Jung S
Glia; 2005 Jan; 49(1):73-83. PubMed ID: 15390096
[TBL] [Abstract][Full Text] [Related]
12. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
13. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
Racke MK; Burnett D; Pak SH; Albert PS; Cannella B; Raine CS; McFarlin DE; Scott DE
J Immunol; 1995 Jan; 154(1):450-8. PubMed ID: 7527821
[TBL] [Abstract][Full Text] [Related]
14. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis.
Ellerman KE; Powers JM; Brostoff SW
Nature; 1988 Jan; 331(6153):265-7. PubMed ID: 2447505
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
16. Recovery of myelin basic protein reactive T cells from spinal cords of Lewis rats with autoimmune encephalomyelitis.
Burns J; Rosenzweig A; Zweiman B; Moskovitz A; Lisak R
J Immunol; 1984 Jun; 132(6):2690-2. PubMed ID: 6202757
[TBL] [Abstract][Full Text] [Related]
17. Perforin and tumor necrosis factor alpha in the pathogenesis of experimental allergic encephalomyelitis: comparison of autoantigen induced and transferred disease in Lewis rats.
Held W; Meyermann R; Qin Y; Mueller C
J Autoimmun; 1993 Jun; 6(3):311-22. PubMed ID: 7691064
[TBL] [Abstract][Full Text] [Related]
18. Suppression of experimental autoimmune neuritis by leflunomide.
Korn T; Toyka K; Hartung HP; Jung S
Brain; 2001 Sep; 124(Pt 9):1791-802. PubMed ID: 11522581
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins.
Achiron A; Mor F; Margalit R; Cohen IR; Lider O; Miron S
J Autoimmun; 2000 Nov; 15(3):323-30. PubMed ID: 11040073
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune effector cells. V.A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis.
Swanborg RH
J Immunol; 1983 Apr; 130(4):1503-5. PubMed ID: 6187808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
